PETER DAHLBERG: Open Payments
NPI 1013311216 · ARVADA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 16 payments from 7 companies in 2025. Trend: 2023 $194 · 2024 $716 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Corium, LLC | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Almatica Pharma LLC | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: ARISTADA, CAPLYTA, INGREZZA, Azstarys, Auvelity, LOREEV XR, COBENFY.
Industry payments across CO — which companies pay providers there.
